Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-835P is a processed pseudogene derived from the U6 small nuclear RNA gene (U6 snRNA). U6 snRNA is an essential component of the spliceosome, the molecular complex responsible for excising introns from pre-mRNA during RNA splicing in eukaryotes. However, RNU6-835P does not encode a functional snRNA or protein, and is categorized as a pseudogene—a non-functional genomic sequence that resembles a functional gene but is generally considered biologically inactive. While some pseudogenes can act as regulatory RNAs (e.g., microRNA sponges or competing endogenous RNAs), there is no evidence that RNU6-835P participates in such functions. Its sequence is present in the human genome likely as a result of evolutionary gene duplication or retrotransposition, and it has no known roles in normal biological processes or disease. As such, it is not considered a therapeutic target and has no associated drugs, mechanisms of action, or biomarker utility.
None; not a known drug target or biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 835, pseudogene (RNU6-835P).